Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL EQUITY
Total Equity ESPR - Esperion Therapeutics, Inc.
-455 M
LAST VALUE
35.87%
2 YEAR CAGR
5.32%
5 YEAR CAGR
-21.72%
10 YEAR CAGR